Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Skin Center Applauds FDA Approval of Botox® to Treat Crow’s Feet; Cautions Consumers to Seek Qualified Injectors
  • USA - English


News provided by

MD COMMUNICATIONS

Sep 20, 2013, 04:30 ET

Share this article

Share toX

Share this article

Share toX


Pittsburgh, PA (PRWEB) September 20, 2013 -- Botox® Cosmetic has received FDA-approval for a new cosmetic indication -- the treatment of dynamic facial wrinkles surrounding the eye area, more commonly known as crow’s feet. The Skin Center Medical Spa, located in Pittsburgh, PA and Columbus, OH recognizes that Botox Cosmetic has been used in an off-label capacity for the treatment of crow’s feet for quite some time; however feels this new FDA approval will offer consumers an additional level of confidence in the safety and effectiveness of the product.    

I started getting Botox a few years ago and I really like the results. Now having FDA-approval to treat crow’s feet…that certainly makes me feel even more comfortable with my decision.

Post this

Adona Kane, 40-year old Mt. Lebanon, PA resident and client of The Skin Center, has been receiving Botox injections twice a year for the past three years to diminish the subtle signs of aging. “I started getting Botox a few years ago to not only soften the wrinkles I had, but to maybe help prevent new wrinkles from forming,” said Kane. “I really like the results and now having FDA approval to treat crow’s feet…that certainly makes me feel even more comfortable with my decision.”

Dominic Brandy, MD, board-certified cosmetic surgeon and founding medical director of The Skin Center Medical Spa, believes the FDA approval to treat crow’s feet will expand the benefit of Botox Cosmetic to consumers wanting to diminish their wrinkles. He cautions, however, that people still need to be aware of who is injecting the Botox and if that person is qualified to perform the injection. “If the injector does not have a proper understanding of facial anatomy and injects the Botox incorrectly, the consumer will have to live with a drooping eyelid or the ‛frozen look‛ until the Botox wears off,” said Brandy. “I strongly recommend asking the provider about their education, training and experience in injecting Botox before undergoing treatment.”

The Skin Center Medical Spa employs expert injectors to administer Botox® Cosmetic, including a dedicated National Trainer for Allergan, Inc., the makers of Botox. Debra Thomas, RN,. The Skin Center’s National Trainer for Allergan, Inc travels the country teaching other medical professionals proper injection techniques as well as the most advanced applications for Botox® Cosmetic.

The Skin Center is the only medical spa and aesthetic practice in the region to be named as one of Allergan, Inc.’s top 50 U.S. Med Spa and Aesthetic Practices in the Partner Privileges Program, respectively making The Skin Center the number one medical spa in Pennsylvania and Ohio based on volume. As a member of the Partner Privileges Program, The Skin Center Medical Spa has the unique benefit of passing along exclusive savings, in the form of elite rebates and special product promotions, directly to our clients. Not only can our clients trust our highly-trained expert injectors and national trainer to deliver the most natural-looking results, they can also rest assured they are getting the best value at The Skin Center as well.

For more than 30 years, The Skin Center Medical Spa’s team of board-certified cosmetic surgeons, board-certified plastic surgeons, vascular surgeons and nurses offer women and men advanced cosmetic plastic surgery and minimally invasive treatments for healthier-looking skin and complete rejuvenation of the face and body.

Botox Cosmetic is the most popular med spa treatment performed at The Skin Center. Results from Botox injections are seen within 7 to 10 days of treatment and the results typically last three to four months. To schedule a consultation, call 1-800-429-1151 or visit our website to learn more.

About The Skin Center Medical Spa
The Skin Center Medical Spa, with three locations in Pittsburgh, Pennsylvania and Columbus, Ohio, is the region's premier, full-service medical spa offering the latest advancements in non-invasive and minimally invasive skin rejuvenation for the treatment of aging skin, hyper-pigmentation, rosacea, unwanted hair, varicose and spider veins, active acne and acne scarring. Established by board-certified cosmetic surgeon Dominic Brandy, MD, in 1981, The Skin Center is one of the few medical facilities in Western Pennsylvania specializing exclusively in cosmetic plastic surgery and anti-aging treatments. Dr. Brandy and his colleague Fernando Colon, MD, board-certified plastic surgeon and medical director of The Skin Center in Columbus, Ohio, have a combined 50 years of experience in cosmetic plastic surgery, and together they have performed nearly 20,000 procedures. The Skin Center’s surgical facilities are accredited by the AAAHC.

NICOLE CONAWAY, MD COMMUNICATIONS, http://www.theskincentermd.com, (412) 414-1404, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.